Stay updated on Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Sign up to get notified when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.

Latest updates to the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedMinor site revision shown as Revision: v3.4.2 replacing v3.4.1; no user-facing content or study information appears affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision history shows a new entry v3.4.1 and removal of v3.4.0. This is a minor metadata update to the page version.SummaryDifference0.1%

- Check34 days agoChange DetectedUI updates include glossary visibility toggles (Show glossary / Hide glossary) and metadata changes such as Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous labels with different capitalization and phrasing were replaced.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study content or page layout (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now includes a consolidated 'Locations' section listing California, Florida, Illinois, Kentucky, Maryland, Michigan, and North Carolina, and the page revision updated to v3.3.3, while standalone state-specific subsections and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.9%

- Check92 days agoChange DetectedThe page shows Revision: v3.3.2 and no longer displays Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of ABBV-951 Subcutaneous Infusions in Parkinson's Clinical Trial page.